Recurrent Ovarian Granulosa Cell Tumor
Recurrent Ovarian Granulosa Cell Tumor, Page: 131-133
2023
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Book Chapter Description
Female patient, 58 years old, was admitted to the hospital with a pelvic mass found for 7 days, 4 years after chemotherapy after ovarian granulosa cell tumor cytoreductive surgery. Postoperative pathology after cytoreductive surgery 4 years ago: left ovarian adult granulosa cell tumor, involving the uterine seromuscular layer and serous layer of the left fallopian tube. No tumor metastasis was found in the pelvic lymph nodes and greater omentum. Ultrasonography examination showed that the whole uterus and bilateral adnexa had been removed. Pelvic effusion: anechoic area above the vagina, 72 mm × 62 mm × 17 mm in size. A mixed echo area of 93 mm × 65 mm × 58 mm was found on the right side of pelvic cavity, with abundant color blood flow; a moderate hypoechoic area was found on the posterior wall of the bladder protruding to pelvic cavity: 25 mm × 26 mm × 16 mm, with punctate color blood flow. Weak echo area was seen on the left side of pelvic cavity: 23 mm × 21 mm × 23 mm, with colored blood flow in the margin. PET-CT: ovarian postoperative change; solid and cystic mass and multiple nodules on the right side of pelvic cavity, with partially increased FDG uptake; and metastasis were considered. Postoperative pathological result: the stump of greater omentum, bladder apex mass, the mass of the anterior wall of sigmoid colon, and the mass of rectouterine pouch, consistent with recurrence of ovarian granulosa cell tumor in correlation with medical history.
Bibliographic Details
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=85207985769&origin=inward; http://dx.doi.org/10.1007/978-981-99-3644-1_26; https://link.springer.com/10.1007/978-981-99-3644-1_26; https://dx.doi.org/10.1007/978-981-99-3644-1_26; https://link.springer.com/chapter/10.1007/978-981-99-3644-1_26
Springer Science and Business Media LLC
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know